Showing results (1261-1270 of 1,341) with videos related to

Sort By:
Pageof 135
Journal of the American College of Cardiology|November 12, 2021
In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection FractionVishal N Rao, Evan Murray, Javed Butler, et al.
American Journal of Hypertension|January 18, 2022
Predicting Out-of-Office Blood Pressure in a Diverse US PopulationBrandon K Bellows, Jingyu Xu, James P Sheppard, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Exposotypes in Psychotic DisordersWalid Yassin, Bryan Kromenacker, James B Green, et al.
Infection|February 1, 2024
Epidemiology and treatment of invasive Bartonella spp. infections in the United StatesMorgan Pizzuti, Pamela Bailey, Caroline Derrick, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2026
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and FinerenoneRajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan, et al.
Open Forum Infectious Diseases|December 5, 2022
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in Non-Hospital Care Settings in 2021Sarah B Green, Ashley H Marx, Elias B Chahine, et al.
Journal of the American Pharmacists Association : Japha|August 6, 2018
Key components of success in a randomized trial of blood pressure telemonitoring with medication therapy management pharmacistsMarySue Beran, Stephen E Asche, Anna R Bergdall, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
<i>Period2</i> 3'-UTR and microRNA-24 regulate circadian rhythms by repressing PERIOD2 protein accumulationSeung-Hee Yoo, Shihoko Kojima, Kazuhiro Shimomura, et al.
Hypertension (Dallas, Tex. : 1979)|June 5, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood PressureRajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan, et al.
Pageof 135